Laxeersiroop

Lactulose, the active ingredient in Laxeersiroop, is an osmotic laxative presented as a syrup for oral use. It is employed to relieve constipation and to lower blood ammonia levels in patients with hepatic encephalopathy, facilitating safer bowel function and metabolic balance. It is formulated to be palatable and is commonly used under medical supervision.

GNH USA supplies Laxeersiroop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with rigorous quality assurance and regulatory compliance across EU and global markets.

Laxeersiroop (lactulose) acts as an osmotic laxative to manage gastrointestinal and hepatic conditions.

- Constipation: softens stool and promotes regular bowel movements. - Hepatic encephalopathy: reduces blood ammonia by acidifying colonic contents, improving neurological symptoms. - Prevention of recurrent hepatic encephalopathy: maintains low ammonia levels to reduce episode frequency.

Lactulose is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Bloating: sensation of abdominal fullness. - Flatulence: increased intestinal gas. - Abdominal cramps: mild to moderate pain. - Diarrhea: loose stools, especially at higher doses. - Nausea: feeling of sickness. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: may cause hyponatremia or hypokalemia. - Dehydration: excessive fluid loss from diarrhea. - Metabolic acidosis: rare but serious shift in blood pH. - Allergic reaction: rash, itching, or swelling. - Severe abdominal pain: persistent or worsening discomfort. - Rectal bleeding: uncommon but requires medical attention.

Lactulose should be used with attention to patient‑specific factors and proper handling.

- Assess renal function: adjust use in patients with renal impairment. - Monitor electrolytes: watch for disturbances due to fluid shifts. - Evaluate hepatic status: use cautiously in severe liver disease. - Contraindicated in galactosemia: avoid in patients with this metabolic disorder. - Use with caution in diabetes: monitor blood glucose as lactulose may affect levels. - Store at ambient temperature: keep in the original container, protect from moisture.

Lactulose may interact with other medicines, requiring awareness of potential effects.

Major Interactions (Avoid): - Antacids: may reduce lactulose efficacy by altering colonic pH. - Rifampin: can decrease lactulose's ammonia‑lowering effect.

Moderate Interactions (Monitor Closely): - Diuretics: increased risk of electrolyte imbalance; monitor serum levels. - Insulin or oral hypoglycemics: possible alteration of glucose control; observe blood sugar. - Mineral supplements (e.g., calcium, magnesium): may cause gastrointestinal upset when combined.